Michael Tetzlaff

24PUBLICATIONS
204CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Dec 15, 2025
RB1 inactivation in cutaneous carcinomas.

Tiffany Liv, Antoine Touzé, David Schrama

|Aug 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.

Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah

|Apr 08, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.

Isabella C Glitza, Yongwoo David Seo, Christine N Spencer

|Nov 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.

Yifan Zhou, Yusra B Medik, Bhakti Patel

|Sep 27, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.

Andrew W Hahn, Ashley V Menk, Dayana B Rivadeneira

|Feb 12, 2021
The tumor immune contexture of salivary duct carcinoma.

Gustavo Schvartsman, Diana Bell, Maria Laura Rubin

Pageof 4

Frequent Collaborators

10 joint publications

Jonathan L Curry

7 joint publications

Carlos Torres-Cabala

7 joint publications

Priyadharsini Nagarajan

5 joint publications

Phyu P Aung